We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.25%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$89.6B
AUM Growth
-$4.64B
(-4.9%)
Cap. Flow
-$5.94B
Cap. Flow
% of AUM
-6.62%
Top 10 Holdings %
Top 10 Hldgs %
12.99%
Holding
2,276
New
117
Increased
853
Reduced
1,022
Closed
220
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$322M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$260M |
| 3 |
Cummins
CMI
|
+$246M |
| 4 |
Wells Fargo
WFC
|
+$242M |
| 5 |
Eli Lilly
LLY
|
+$177M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$334M |
| 2 |
RTN
Raytheon Company
RTN
|
+$310M |
| 3 |
Micron Technology
MU
|
+$306M |
| 4 |
Valero Energy
VLO
|
+$301M |
| 5 |
HF Sinclair
DINO
|
+$289M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.11% |
| 2 | Healthcare | 17.02% |
| 3 | Consumer Discretionary | 12.05% |
| 4 | Financials | 11.02% |
| 5 | Industrials | 10.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CKH
1926
DELISTED
Seacor Holdings Inc.
CKH
| $250K | ﹤0.01% |
+5,270
| New | +$231K |
|
1927
Goosehead Insurance
GSHD
$2.32B
| $248K | ﹤0.01% |
+5,198
| New | +$181K |
|
1928
Tucows
TCX
$175M
| $247K | ﹤0.01% |
4,041
+43
| +1% | +$3.09K |
|
|
BVH
1929
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $247K | ﹤0.01% |
10,049
-512
| -5% | -$13.1K |
|
|
CRAY
1930
DELISTED
Cray, Inc.
CRAY
| $247K | ﹤0.01% |
+7,091
| New | +$219K |
|
|
LABL
1931
DELISTED
Multi-Color Corp
LABL
| $247K | ﹤0.01% |
4,952
| – | – |
|
1932
Anika Therapeutics
ANIK
$287M
| $244K | ﹤0.01% |
6,013
-9,869
| -62% | -$360K |
|
|
SGI
1933
Somnigroup International
SGI
$13.7B
| $244K | ﹤0.01% |
+13,584
| New | +$219K |
|
1934
Provident Financial Services
PFS
$3.19B
| $243K | ﹤0.01% |
10,028
+38
| +0.4% | +$962 |
|
1935
World Acceptance Corp
WRLD
$873M
| $243K | ﹤0.01% |
1,479
-3,363
| -69% | -$459K |
|
1936
Houlihan Lokey
HLI
$9.02B
| $242K | ﹤0.01% |
5,429
-384
| -7% | -$17.9K |
|
1937
Tredegar Corp
TG
$310M
| $240K | ﹤0.01% |
14,444
-4,866
| -25% | -$82.2K |
|
|
CIM
1938
Chimera Investment
CIM
$1B
| $239K | ﹤0.01% |
4,217
-1,990
| -32% | -$113K |
|
|
NFBK
1939
DELISTED
Northfield Bancorp
NFBK
| $235K | ﹤0.01% |
15,026
-829
| -5% | -$12.4K |
|
|
TRHC
1940
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $234K | ﹤0.01% |
4,691
-34,700
| -88% | -$1.73M |
|
1941
Children's Place
PLCE
$59.8M
| $233K | ﹤0.01% |
2,446
-78,859
| -97% | -$8.05M |
|
1942
National Bank Holdings
NBHC
$1.9B
| $232K | ﹤0.01% |
6,402
-7,197
| -53% | -$260K |
|
|
TVRD
1943
Tvardi Therapeutics
TVRD
$23.4M
| $231K | ﹤0.01% |
+298
| New | +$209K |
|
1944
Intrepid Potash
IPI
$469M
| $229K | ﹤0.01% |
6,815
+2,138
| +46% | +$74.5K |
|
|
ATRS
1945
DELISTED
Antares Pharma, Inc.
ATRS
| $228K | ﹤0.01% |
69,293
| – | – |
|
1946
Starwood Property Trust
STWD
$6.09B
| $227K | ﹤0.01% |
9,970
-6,700
| -40% | -$152K |
|
1947
Core Laboratories
CLB
$521M
| $226K | ﹤0.01% |
4,390
-44
| -1% | -$2.58K |
|
1948
Smith & Wesson
SWBI
$637M
| $226K | ﹤0.01% |
+32,612
| New | +$231K |
|
|
DERM
1949
DELISTED
Dermira, Inc.
DERM
| $226K | ﹤0.01% |
23,658
-30,347
| -56% | -$327K |
|
1950
Willdan Group
WLDN
$1.3B
| $225K | ﹤0.01% |
6,036
-6,359
| -51% | -$230K |
|
Similar funds
VGA
AQR Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, AQR Capital Management held 2,276 positions worth $89.6B, down 4.9% from $94.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management withdrew a net $5.94B in Q2 2019, closing 220 positions and reducing 1,022 holdings. Its most notable exit was Stellantis, an estimated $334M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, AQR Capital Management opened a new position in Optimum Communications Inc worth $28.8M.
- AQR Capital Management's largest Q2 2019 buy was Optimum Communications Inc: 1,190,376 shares worth $28.8M.
- AQR Capital Management added most to Procter & Gamble in Q2 2019, an estimated $322M increase.
- AQR Capital Management's biggest Q2 2019 reduction was Raytheon Company, cutting an estimated $310M.
- AQR Capital Management fully exited Stellantis in Q2 2019, selling an estimated $334M.
- AQR Capital Management's ten largest holdings make up 13% of its $89.6B portfolio in Q2 2019.
- AQR Capital Management opened 117 new positions and closed 220 in Q2 2019.
- AQR Capital Management's portfolio value fell 4.9% quarter-over-quarter to $89.6B.
Based on AQR Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.